Is the SCND CEO’s stock option grant an open-market share purchase?

No. The transaction is coded as a grant or award acquisition of derivative securities, not an open-market purchase. It reflects stock-based compensation, giving the CEO the right to buy shares later rather than buying shares directly in the market now.

50,000 options granted to Scientific Industries (SCND) CEO in lieu of salary

Q: What are the key terms of the SCND CEO’s 50,000 stock option grant?

The CEO’s 50,000 stock options have an exercise price of $0.60 per share , with an exercise date of February 17, 2027 and an expiration date of February 17, 2036 . These terms define when and at what price the options can be exercised.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Scientific Industries Inc. reported that President and CEO Helena R. Santos received a grant of stock options to acquire 50,000 shares of common stock. The options carry an exercise price of $0.60 per share, become exercisable starting on February 17, 2027, and expire on February 17, 2036. According to the disclosure, these options were granted in lieu of salary and vest over one year at a rate of 1/12th per month. After this grant, Santos directly holds 433,388 derivative securities related to the company.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SANTOS HELENA R

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	50,000	$0.00	--

Holdings After Transaction: Stock Option — 433,388 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Option grant size: 50,000 options Exercise price: $0.60 per share Exercise date: February 17, 2027 +4 more

7 metrics

Option grant size 50,000 options Stock option grant to CEO on February 17, 2026

Exercise price $0.60 per share Conversion or exercise price for granted options

Exercise date February 17, 2027 Date options become exercisable

Expiration date February 17, 2036 Date options expire

Underlying shares 50,000 shares Common stock underlying the stock options

Derivative holdings after grant 433,388 securities Total derivative securities held directly after transaction

Vesting schedule 1/12th per month over 1 year Options granted in lieu of salary

Key Terms

Stock Option, Grant, award, or other acquisition, derivative securities, vesting 1 year - 1/12th per month, +1 more

5 terms

Stock Option financial

"security_title: "Stock Option""

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

derivative securities financial

"derivativeTransactionCount and total derivative securities following transaction"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

vesting 1 year - 1/12th per month financial

"footnote: "Vesting 1 year - 1/12th per month.""

in lieu of salary financial

"footnote: "Options granted to Registrant in lieu of salary.""

Form 4 Insider Transactions: What Each Field Means →

04/01/2026 - 12:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SANTOS HELENA R

(Last)

(First)

(Middle)

(Street)

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SCIENTIFIC INDUSTRIES INC [ SCND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option	$0.6	02/17/2026	02/17/2026	A		50,000		02/17/2027⁽¹⁾	02/17/2036	Common Stock	50,000	⁽¹⁾	433,388	D

Explanation of Responses:

1. Options granted to Registrant in lieu of salary. Vesting 1 year - 1/12th per month.

	Helena Santos	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did SCIENTIFIC INDUSTRIES INC (SCND) report for Helena R. Santos?

SCIENTIFIC INDUSTRIES INC reported that President and CEO Helena R. Santos received a grant of stock options for 50,000 shares. These options represent compensation, not an open-market purchase, and give her the right to buy common stock at a fixed exercise price.

What are the key terms of the SCND CEO’s 50,000 stock option grant?

The CEO’s 50,000 stock options have an exercise price of $0.60 per share, with an exercise date of February 17, 2027 and an expiration date of February 17, 2036. These terms define when and at what price the options can be exercised.

How do the new SCND options granted to the CEO vest over time?

The filing states the options were granted in lieu of salary and vest over one year. Vesting occurs at a rate of 1/12th per month, meaning a portion becomes exercisable each month during the one-year vesting period.

What is the CEO’s derivative position in SCND after this stock option grant?

After receiving the 50,000 stock options, Helena R. Santos is reported to directly hold 433,388 derivative securities. This total includes the new options and reflects her overall derivative-based exposure to SCIENTIFIC INDUSTRIES INC common stock.